Jasper Therapeutics (JSPR) Earnings Date, Estimates & Call Transcripts $2.90 +0.05 (+1.75%) As of 12:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Jasper Therapeutics Earnings Summary Jasper Therapeutics posted Q2 2025 earnings on August 13, 2025, reporting an EPS of -$1.74, which missed the consensus estimate of -$1.20 by $0.54. With a trailing EPS of -$6.01, Jasper Therapeutics' earnings are expected to decrease next year, from ($4.47) to ($4.62) per share. Upcoming Q3 Earnings DateNov. 6Before Market OpensEstimatedConsensus EPS (Aug. 13) -$1.20 Actual EPS (Aug. 13) -$1.74 Missed By -$0.54 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)JSPR Upcoming EarningsJasper Therapeutics' next earnings date is estimated for Thursday, November 6, 2025, based on past reporting schedules. Powered by Get Jasper Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jasper Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataJSPR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Jasper Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.48-$0.91-$1.20Q2 20252-$1.48-$1.37-$1.43Q3 20252-$1.48-$0.75-$1.12Q4 20252-$1.32-$0.73-$1.03 FY 2025 8 -$5.76 -$3.76 -$4.76 Q1 20261-$0.51-$0.51-$0.51Q2 20261-$0.49-$0.49-$0.49Q3 20261-$0.58-$0.58-$0.58Q4 20261-$0.59-$0.59-$0.59 Jasper Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/6/2025(Estimated)--------8/13/2025Q2 2025-$1.20-$1.74 -$0.54-$1.74--5/12/2025Q1 2025-$1.17-$1.41 -$0.24-$1.41--2/27/2025Q4 2024-$1.27-$1.62 -$0.35-$1.62--11/7/2024--$1.09-$1.24 -$0.15-$1.24--8/13/2024--$1.09-$0.97+$0.12-$0.97--5/14/2024Q1 2024-$1.26-$1.03+$0.23-$1.03--3/4/2024Q4 2023-$1.65-$1.50+$0.15-$1.50--11/9/2023Q3 2023-$1.50-$1.60 -$0.10-$0.16-- Jasper Therapeutics Earnings - Frequently Asked Questions When is Jasper Therapeutics' earnings date? Jasper Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based off last year's report dates. Learn more on JSPR's earnings history. Did Jasper Therapeutics beat their earnings estimates last quarter? In the previous quarter, Jasper Therapeutics (NASDAQ:JSPR) missed the analysts' consensus estimate of ($1.20) by $0.54 with a reported earnings per share (EPS) of ($1.74). Learn more on analysts' earnings estimate vs. JSPR's actual earnings. How much profit does Jasper Therapeutics generate each year? Jasper Therapeutics (NASDAQ:JSPR) has a recorded net income of -$71.27 million. JSPR has generated -$6.01 earnings per share over the last four quarters. What is Jasper Therapeutics' EPS forecast for next year? Jasper Therapeutics' earnings are expected to decrease from ($4.47) per share to ($4.62) per share in the next year. More Earnings Resources from MarketBeat Related Companies THTX Earnings CLLS Earnings BHST Earnings CTOR Earnings NKTX Earnings KYTX Earnings BDTX Earnings FTLF Earnings CGEN Earnings PLX Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles DLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals? This page (NASDAQ:JSPR) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredWinning the AI WarWhat’s really driving the trade wars, reshoring, and sweeping executive orders? According to Porter Stansberry...Porter & Company | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access